250 related articles for article (PubMed ID: 12527712)
21. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.
Ribeiro-Silva A; Ramalho LN; Garcia SB; Brandão DF; Chahud F; Zucoloto S
Histopathology; 2005 Nov; 47(5):458-66. PubMed ID: 16241993
[TBL] [Abstract][Full Text] [Related]
22. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation.
Ng SB; Sittampalam K; Goh YH; Eu KW
Pathology; 2003 Feb; 35(1):42-6. PubMed ID: 12701683
[TBL] [Abstract][Full Text] [Related]
23. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
24. Cystic tumor of the atrioventricular node of the heart appears to be the heart equivalent of the solid cell nests (ultimobranchial rests) of the thyroid.
Cameselle-Teijeiro J; Abdulkader I; Soares P; Alfonsín-Barreiro N; Moldes-Boullosa J; Sobrinho-Simões M
Am J Clin Pathol; 2005 Mar; 123(3):369-75. PubMed ID: 15716232
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas.
Brinck U; Ruschenburg I; Di Como CJ; Buschmann N; Betke H; Stachura J; Cordon-Cardo C; Korabiowska M
Int J Mol Med; 2002 Dec; 10(6):707-11. PubMed ID: 12429996
[TBL] [Abstract][Full Text] [Related]
26. p63 in Primary Cutaneous Carcinosarcoma.
Suh KY; Lacouture M; Gerami P
Am J Dermatopathol; 2007 Aug; 29(4):374-7. PubMed ID: 17667171
[TBL] [Abstract][Full Text] [Related]
27. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
28. Thinking "out of the nest"--a reply to "a stem-cell role for thyroid solid cell nests [letter]".
Burstein DE; Unger P; Nagi C; Wang BY
Hum Pathol; 2005 May; 36(5):591-2. PubMed ID: 15948130
[No Abstract] [Full Text] [Related]
29. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
[TBL] [Abstract][Full Text] [Related]
33. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
Chen YK; Hsue SS; Lin LM
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
[TBL] [Abstract][Full Text] [Related]
34. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of the expression of S-100 protein, epithelial membrane antigen, cytokeratin and carcinoembryonic antigen in thyroid lesions.
Mitselou A; Vougiouklakis TG; Peschos D; Dallas P; Boumba VA; Agnantis NJ
Anticancer Res; 2002; 22(3):1777-80. PubMed ID: 12168868
[TBL] [Abstract][Full Text] [Related]
36. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
Kim YW; Do IG; Park YK
Pathol Res Pract; 2006; 202(11):759-65. PubMed ID: 17029809
[TBL] [Abstract][Full Text] [Related]
37. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
[TBL] [Abstract][Full Text] [Related]
38. The p53-homologue p63 may promote thyroid cancer progression.
Malaguarnera R; Mandarino A; Mazzon E; Vella V; Gangemi P; Vancheri C; Vigneri P; Aloisi A; Vigneri R; Frasca F
Endocr Relat Cancer; 2005 Dec; 12(4):953-71. PubMed ID: 16322335
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitous p63 expression in human esophageal squamous cell carcinoma.
Hara T; Kijima H; Yamamoto S; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Takazawa K; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2004 Aug; 14(2):169-73. PubMed ID: 15254760
[TBL] [Abstract][Full Text] [Related]
40. Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin.
Thurfjell N; Coates PJ; Vojtesek B; Benham-Motlagh P; Eisold M; Nylander K
Int J Mol Med; 2005 Dec; 16(6):1065-70. PubMed ID: 16273287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]